FDA Inspection
Oklahoma Blood InstituteOklahoma Blood Institute – FDA Inspection, Aug 26, 2026
Record Details
This FDA Inspection record concerns Oklahoma Blood Institute, with an inspection on August 26, 2026, issued by the Dallas District Office, covering biologics.
View Company Profile
ID · c257f8b2-9f45-401b-ac2d-cbef054adbec
Inspection Facts
- Inspection number
- 1284988
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.60(a)Equipment observed, standardized, calibrated
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Oklahoma Blood Institute
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 7, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 16, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 8, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 27, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Oklahoma Blood Institute
- FDA Inspection 1040193 - 2017-12-07
- FDA Inspection 945909 - 2015-10-16
- FDA Inspection 830972 - 2013-05-08
- FDA Inspection 727157 - 2011-05-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.